Sangart's Series G - II Round

Sangart raised a round of funding on May 24, 2012.

Sangart is a biopharmaceutical company focused on oxygen-therapeutic agents, providing products to patients in need. Sangart was founded in 1998 based on discoveries arising from over two decades of …

Articles about Sangart's Series G - II Round: